Skip to content

The Use of Manual Therapy to Treat Low-Back and Hip Pain

The Use of Myofascial Release in Lumbopelvic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00410397
Enrollment
27
Registered
2006-12-12
Start date
2006-12-31
Completion date
2007-02-28
Last updated
2008-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Pain

Keywords

Low back pain, Hip pain

Brief summary

Low back pain (LBP) is a common problem in the adult population with many approaches to treatment, but no clear answer. One of the causes of LBP, musculoskeletal pain, can be triggered by spasm of the deep muscles of the back and pelvis. This study, therefore, focuses on treating pelvic muscle pain as a way of lessening LBP.

Detailed description

Osteopathic manipulative medicine (OMM) is a well-researched standard of care in the treatment of low back pain (LBP). Under the heading of OMM, many different modalities exist to decrease a patient's somatic dysfunction. Among the most commonly used are high velocity (thrusting through an immobilized joint) and muscle energy (engaging a restrictive barrier using the patient's own strength). Although a very common complaint, there is no exact etiology for LBP. Many different theories exist, including postural disturbances, leg length discrepancies, and even genetic predispositions. A study in Spine finds that among those with chronic LBP there is a subgroup of people with reduced hip flexion, and concludes that hip motion should be considered in treatment of patients with LBP. Currently, there exists no research on the manipulation of hip flexors in the treatment of LBP. This study, therefore, will test the efficacy of OMM on the deep pelvic musculature as a way of decreasing LBP.

Interventions

Pelvic balancing, myofascial release of the anterior pelvis.

PROCEDURESham Manipulation

Neutral positional, gentle palpation

Sponsors

Oklahoma State University Center for Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Age-older than 18 years and younger than 65 years * Lumbopelvic pain

Exclusion criteria

* Cardiovascular disease (heart-failure, myocardial infarction, hypertension) * Diabetes * Rheumatoid Arthritis * Osteoarthritis * Chronic Illness * Pregnancy-self reported * Neurodegenerative Disease * Osteopenia * Osteoporosis * Metastatic Cancer

Design outcomes

Primary

MeasureTime frame
Reduction in low back pain on a 1-10 scale.Immediately following treatment.

Secondary

MeasureTime frame
Reduction in low back pain on a 0-10 scale.6-8 hours after treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026